Letters to the Editor
Readers And Tweeters Add Two Cents On Amazon Venture To Repackage Health Care
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
Health Industry
2,421-2,440 of 4,029 results
-
-
Community Health Centers Caught In ‘Washington’s Political Dysfunction’
The centers, which serve 27 million people, get about 20 percent of their funding from the federal government. But that revenue is slated to end on March 31.
-
As States Target High Drug Prices, Pharma Targets State Lawmakers
In Louisiana, the wining and dining of lawmakers by scores of pharma lobbyists proves a valuable lesson on how to win statehouse votes and influence profits.
By Jay Hancock and Shefali Luthra -
Expert Advice For The Corporate Titans Taking On Health Care
Amazon, Berkshire Hathaway and JPMorgan Chase & Co. are partnering up to address employee health care costs and improve satisfaction. Can they deliver? And would repackaging health insurance involve drones?
-
My Grandmother Was Italian. Why Aren’t My Genes Italian?
Popular DNA ancestry tests don't always find what people expect. That's because of how DNA rearranges itself when egg meets sperm — and the quirks of genetic databases.
-
Podcast: ‘What The Health?’ CHIP (Finally) Gets Funded
In this episode of “What The Health?†Julie Rovner of Kaiser Health News, Joanne Kenen of Politico, Alice Ollstein of Talking Points Memo and Paige Winfield Cunningham of The Washington Post discuss the short-term spending bill passed by Congress that reopened the federal government and funded the Children’s Health Insurance Program for six years. The panelists also discussed the health programs still awaiting funding, and the intersection of religion and women’s health services at the Department of Health and Human Services.
-
Big Pharma Greets Hundreds Of Ex-Federal Workers At The ‘Revolving Door’
A KHN data analysis finds that the door of opportunities connecting Capitol Hill, the federal government and the drug industry likely spins in Big Pharma’s favor.
-
Hospitals’ Best-Laid Plans Upended By Disaster
An onslaught of fires, shootings and storms across the country last year tested hospital readiness. Now, leaders are using their experiences to address shortcomings that surfaced amid the chaos.
-
University Under Fire For Off-The-Grid Herpes Vaccine Experiments
Southern Illinois University’s medical school has halted all herpes research, one of its most high-profile projects, amid growing controversy over a researcher’s unauthorized methods offshore and in the U.S.
-
Judge Orders New Olympus Trial Over Superbug Death
The Seattle jurist finds that Olympus Corp. failed to properly disclose evidence that it knew of concerns about cleaning problems with its redesigned medical scopes years before they hit the market and were linked to dozens of deaths. The company maintains the devices were not defective and intends to appeal.
By Chad Terhune -
It’s In The Mail: Aetna Agrees To $17M Payout In HIV Privacy Breach
In a low-tech snafu, information about HIV treatment was visible through the cellophane window on envelopes sent to about 12,000 consumers.
-
Podcast: What The Health? Our First Live Show: What The Health Will Happen In 2018?
In this episode of “What The Health?†— taped before a live audience — panelists discuss the potential federal government shutdown and what may be in store for health in 2018. They are joined by former Medicare and Medicaid head Tom Scully.
-
Home Care Agencies Often Wrongly Deny Medicare Help To The Chronically Ill
Agencies sometimes turn away Medicare beneficiaries with chronic health problems by incorrectly claiming Medicare won't pay for their services, say patient advocates.
By Susan Jaffe -
Inside The Global Race To Deliver A Vital Radioactive Isotope Used To Detect Cancer
Moly-99, as it’s called, is created in just six government-owned nuclear research reactors — none in North America — raising concerns about the reliability of the supply.
By Sarah Varney -
When You Need A Breast Screening, Should You Get A 3-D Mammogram?
The newer images are more expensive, but it’s not yet clear if they are more effective in catching cancers that will kill.
-
J.P. Morgan Health Conference All About The Deals Amid Uncertainty For Millions
The lofty ideas floated and billion-dollar deals sealed at J.P. Morgan’s elite annual conference stand in stark contrast to the uncertainty that clouds health care outside its confines.
-
Facebook Live: It’s 2018, Can Big Pharma Hold The Line Against Pricing Controls?
In this chat, KHN senior correspondent Jay Hancock discusses how drug-pricing battles could play out this year in D.C., state legislatures and beyond. What do we know about the drug industry’s agenda to quiet the drumbeat of cost control and transparency proposals? How will they officials target their efforts? Will the battles take place at the state level? Senior editor Stephanie Stapleton moderates.
-
Listen: How A ‘Hippie Clinic’ In San Francisco Inspired A Medical Philosophy
The Haight Ashbury Free Clinic still serves people living on the fringes in San Francisco. This radio story recounts its 51-year history.
-
Despite Prod By ACA, Tax-Exempt Hospitals Slow To Expand Community Benefits
The Affordable Care Act mandated that hospitals exempt from taxes work to provide health benefits to the community. But a study finds that has been slow to get off the ground.
-
Grassley Calls For ‘Corrective Action’ On Abuses In Herpes Vaccine Research
The Republican senator sent out letters to the Food and Drug Administration and HHS demanding an explanation about a rogue herpes vaccine trial.